XPD 751 Gln/Gln genotype depicts a significant increased risk for breast cancer (OR = 1.7, 95% CI 1.02–2.8), particularly in premenopausal female patients (OR = 2.6; 95% CI 1.33–4.79). Here, ERCC2 is linked to breast carcinoma.